Home › Melanoma › Michigan › Flint
Melanoma clinical trials in Flint, MI
3 studies for Melanoma are looking for participants at sites in and around Flint (within about 30 miles). Open a study to see who can join and how to contact the study team.
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Cancer Hematology Centers - Flint, Flint
- Genesee Hematology Oncology PC, Flint
- Genesys Hurley Cancer Institute, Flint
- and 1 more
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Cancer Hematology Centers - Flint, Flint
- Genesee Hematology Oncology PC, Flint
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN32 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Atlanta, GA21 studies
- Columbus, OH21 studies
- Salt Lake City, UT21 studies
- Durham, NC21 studies
Other studies in Flint
- Lung Cancer10 studies
- Breast Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer7 studies
- Colorectal Cancer6 studies
- Cancer (all types)6 studies
- Acute Myeloid Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
- Lupus4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.